Fatty acids build cell membranes, and the polyunsaturated group includes the
essential omega-3s: alpha-linolenic acid, eicosapentaenoic acid, and
docosahexaenoic acid. Looking at the literature, it is clear that eating fish and
marine omega-3s is linked to a lower risk of cardiovascular disease, largely because
these fats help lower triglycerides and blood pressure while helping fight
inflammation. High doses of pure EPA (4 g/day) have been shown to effectively cut
the risk of cardiac events, whereas the standard doses of mixed EPA and DHA often
fail to yield the same results in the general population. In the brain, DHA is the
dominant fatty acid, playing a vital function in preserving cell membrane fluidity
and helping neurotransmitters function properly. Animal research shows that
omega-3s safeguard the brain during ischemic events by preventing cell death and
reducing inflammation, and they also show promise in relieving depression
symptoms, with EPA being especially effective. These benefits come with risk,
however, as using high doses has been linked to a dose-dependent chance of
developing atrial fibrillation. Ultimately, this analysis points out the need to
personalize supplementation, accounting for the distinct effects of different fatty
acids rather than treating them all the same.
Keywords: Fatty acids, EPA and DHA, omega-3 fatty acid, heart health
